SIOX

Sio Gene Therapies Inc. Common Stock

SIOX

Market cap $30.7M

Delisted

SIOX was delisted on the 22nd of March, 2023.

About: Sio Gene Therapies Inc is a clinical-stage company that is focused on gene therapy for neurodegenerative diseases. The company is developing its pipeline for the treatment of debilitating diseases, including Parkinson's disease, GM1 gangliosidosis, and GM2 gangliosidosis.

Employees: 12

Healthcare Drug Manufacturers - General

Financial journalist opinion

Neutral

GlobeNewsWire

1 year ago

Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share

PARSIPPANY, N.J., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Sio Gene Therapies, Inc. ("Sio") today announced that it expects to file a certificate of dissolution (the "Certificate of Dissolution") with the Secretary of State of the State of Delaware, as contemplated by the Plan of Complete Liquidation and Dissolution (the "Plan") previously approved by Sio's Board of Directors and stockholders, on February 7, 2024. The Certificate of Dissolution, which is expected to become effective at 4:00 p.m. Eastern Time on February 7, 2024 (the "Effective Time"), provides for the dissolution of Sio under the General Corporation Law of the State of Delaware (the "DGCL").

See News Rankings

Charts implemented using Lightweight Charts™

Sio Gene Therapies Inc. Common Stock SIOX Market cap $30.7M

Financial journalist opinion

Sio Gene Therapies Inc. Common Stock

SIOX

Market cap $30.7M